| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |